Etin-Osa Osa to Breast Neoplasms
This is a "connection" page, showing publications Etin-Osa Osa has written about Breast Neoplasms.
Connection Strength
0.419
-
Osa EO, DeWyngaert K, Roses D, Speyer J, Guth A, Axelrod D, Fenton Kerimian M, Goldberg JD, Formenti SC. Prone breast intensity modulated radiation therapy: 5-year results. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):899-906.
Score: 0.245
-
Bozza C, Puglisi F, Lambertini M, Osa EO, Manno M, Del Mastro L. Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients. Endocr Relat Cancer. 2014 Feb; 21(1):R51-65.
Score: 0.060
-
Bozza C, Osa EO, Puglisi F. Primary therapy in breast cancer: what have we learned from landmark trials? Womens Health (Lond). 2013 Nov; 9(6):583-93.
Score: 0.059
-
Bonotto M, Bozza C, Di Loreto C, Osa EO, Poletto E, Puglisi F. Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase? Clin Breast Cancer. 2013 Jun; 13(3):167-72.
Score: 0.055